Your account is not claimed yet. You can sign up with ORCID to claim your account.

Keisuke Katsushima

Years Active: 2020-2023
Publications (10 Years): 5

This page only lists publications with an associated author ORCID identifier.

Publications

Keisuke Katsushima, Kandarp Joshi, Ranjan J Perera
Diagnostic and therapeutic potential of circular RNA in brain tumors. Neuro-oncology advances 5 (1) (2023)
Bongyong Lee, Keisuke Katsushima, Rudramani Pokhrel, Menglang Yuan, Stacie Stapleton, George I Jallo, Robert J Wechsler-Reya, Charles G Eberhart, Animesh Ray, Ranjan J Perera
The long non-coding RNA SPRIGHTLY and its binding partner PTBP1 regulate exon 5 skipping of SMYD3 transcripts in group 4 medulloblastomas. Neuro-oncology advances 4 (1) (2022)
Keisuke Katsushima, George I Jallo, Charles G Eberhart, Ranjan J Perera
Long non-coding RNAs in brain tumors. NAR cancer 3 (1) (2021)
Yoshihiko Tasaki, Miho Suzuki, Keisuke Katsushima, Keiko Shinjo, Kenta Iijima, Yoshiteru Murofushi, Aya Naiki-Ito, Kazuki Hayashi, Chenjie Qiu, Akiko Takahashi, Yoko Tanaka, Tokuichi Kawaguchi, Minoru Sugawara, Tomoya Kataoka, Mitsuru Naito, Kanjiro Miyata, Tetsuo Noda, Wentao Gao, Satoru Takahashi, Kazunori Kimura, Yutaka Kondo
Cancer-Specific Targeting of Taurine-Upregulated Gene 1 Enhances the Effects of Chemotherapy in Pancreatic Cancer. Cancer research 81 (7) (2021)
Haruhito Totani, Keiko Shinjo, Miho Suzuki, Keisuke Katsushima, Shoko Mase, Ayako Masaki, Asahi Ito, Masaki Ri, Shigeru Kusumoto, Hirokazu Komatsu, Takashi Ishida, Hiroshi Inagaki, Shinsuke Iida, Yutaka Kondo
Autocrine HGF/c-Met signaling pathway confers aggressiveness in lymph node adult T-cell leukemia/lymphoma. Oncogene 39 (35) (2020)

Keisuke Katsushima.css-eqlu8i{font-size:small;padding-left:4px;}